Abstract
Official letter of the FDA to a sponsor company, informing e.g. on an NDA decision by the agency; three types exist: (i) an approval letter which allows marketing of the product, (ii) an approvable letter which lists minor issues to be resolved before a definite approval, (iii) a not approvable letter which describes important deficiencies that preclude approval unless corrected; → see also new drug application.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag/Wien
About this chapter
Cite this chapter
Nahler, G. (2009). action letter. In: Dictionary of Pharmaceutical Medicine. Springer, Vienna. https://doi.org/10.1007/978-3-211-89836-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-211-89836-9_15
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-89835-2
Online ISBN: 978-3-211-89836-9
eBook Packages: MedicineMedicine (R0)